Dr. Ian James Martins is a Doctor of Science in Nutrition and Doctor of Medicine in Diabetology (Honoris Causa, https://sites.google.com/site/internationalindexing/advisory-board). He is an Editor/Reveiwer for Open Acess Pub/MDPI journals, Advisory Board Member for Photon Journal, various international journals and a Fellow of the International Agency for Standards and Rating. Semantic Scholar profile for Ian James Martins acknowledges 133 highly influential citations. Chief Editor for International Journal of Diabetes Research (2014-2019), Research and Reviews: Neuroscience (2016-2019) and Journal of Diabetes and Clinical Studies (2017-2019). BIT Member (BIT Congress. Inc) with an H-index of 65, Citations >5000 RESEARCHGATE RESEARCHER : Ian James Martins (www.google.com.au) places RG score (> 96%). ORCID CONNECTING RESEARCHER (Ian James Martins (0000-0002-2390-1501). Frontiers in Genetics places Ian James Martins outputs > 99% of all Loop authors. Winner (World Academic Championship -2017) in Diabetes and Nutrition and Medical Science (Trophy of the World Championship). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. Research Online (ECU) has selected 37 publications under Global analysis. BIT Member (BIT Congress. Inc) with an h-index of 65, (ResearchGate STATs (28), Scopus Author ID: 7103152779/Mendeley STATS (21), UWA Research Repository (16). Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu (220 Public Mentions). 72 international certificates from various conferences/journals in relation to anti-aging, health and disease. Top Peer Reveiwer 2019, Global Peer Reveiw Awards, PUBLONS, RANKING TOP 1% in the field 22 Essential Science Indicators research fields. Keynote speaker, Chair and Organizing Member for approx. 80 conferences in 2014-2020.
Dr. Ian James Martins research interests are Unhealthy diets overide the heat shock gene with Programmed cell death. A. Dr. Martins research with relevance to diet, diabetes and neurodegenerative diseases builds upon his past > 140 publications that generates outputs that will have relevant and significant impact to the global community. The incidence of diabetes and non alcoholic fatty liver disease (NAFLD) has been predicted to increase to 21% by 2050. Novel and critical elements of scholarly peer review provides information that the heat shock gene Sirtuin 1 is repressed with relevance to diabetes, neurological diseases and Alzheimer's disease. Major unsolved challenges to advances in biology may now provide evidence to reverse Sirtuin 1 dysfunction that is connected to primarily to heat shock protein metabolism and secondly to toxic amyloid beta metabolism with mitochondrial apoptosis in liver and brain cells. Core body temperature dysfunction inactivates insulin therapy with Sirt 1 repression involved in the induction of NAFLD and Type 3 diabetes. Development of a BLOOD TEST has been of critical interest to the for metabolic disease with relevance to diabetes and neurodegenerative diseases. B. Interests in Biomarker Research has escalated with relevance to mitochondrial survival and organ disease in diabetes and Alzheimerís disease. The global chronic disease epidemic is expected to cost Biomarker Research between 15 to 20 billion dollars in the next 20 years. Biomarkers such as Sirtuin 1 are now relevant to mitochondrial apoptosis versus mitochondrial biogenesis and may supersede the various biomarkers for mitochondrial survival relevant to diabetes, Alzheimerís disease and neurodegenerative disease research.